⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28475499 | 0.88 | CHRM1 (0.52) | — | |
| SCHEMBL11633541 | 0.84 | CA2 (0.43) | — | |
| SCHEMBL348796 | 0.82 | — | — | |
| SCHEMBL143441 | 0.79 | — | — | |
| SCHEMBL5870378 | 0.79 | — | — | |
| SCHEMBL4410902 | 0.79 | CHRM1 (0.44) | — | |
| SCHEMBL5870376 | 0.79 | — | — | |
| SCHEMBL27535823 | 0.77 | CHRM1 (0.76) | — | |
| SCHEMBL9381886 | 0.76 | — | — | |
| SCHEMBL13477877 | 0.75 | CA2 (0.68) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 24 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2352721-B1 | NOVEL PROCESS FOR THE PREPARATION OF AMINO ACID DERIVATIVES | UCB PHARMA GMBH (DE) | 2013-03-27 | — | — | EP | claimed |
| EP-3375771-B1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | UBE CORP (JP) | 2025-11-26 | — | — | EP | disclosed |
| US-11623943-B2 | Method for producing lacosamide and intermediate thereof | API CORPORATION (JP) | 2023-04-11 | — | — | US | disclosed |
| US-20210188904-A1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | API CORPORATION (JP) | 2021-06-24 | — | — | US | disclosed |
| US-10975117-B2 | Method for producing lacosamide and intermediate thereof | API CORPORATION (JP) | 2021-04-13 | — | — | US | disclosed |
| EP-3659997-A1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | API Corporation (JP) | 2020-06-03 | — | — | EP | disclosed |
| US-20180371013-A1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | API CORPORATION (JP) | 2018-12-27 | — | — | US | disclosed |
| EP-3375771-A1 | METHOD FOR PRODUCING LACOSAMIDE AND INTERMEDIATE THEREOF | API Corporation (JP) | 2018-09-19 | — | — | EP | disclosed |
| US-8344181-B2 | Obesity, type 2 diabetes, hyperlipidemia, hypertension, arteriosclerosis, coronary heart diseases | JANSSEN PHARMACEUTICA N.V. (BE) | 2013-01-01 | — | — | US | disclosed |
| CN-1930137-B | Benzothiazepine and benzoazepine compounds | ASAHI KASEI PHARMA CORP | 2011-07-20 | — | — | CN | disclosed |
| WO-2006024627-A9 | N-2 ADAMANTANYL-2-PHENOXY-ACETAMIDE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS | JANSSEN PHARMACEUTICA NV (BE) | 2008-02-14 | — | — | WO | disclosed |
| EP-1796657-A2 | N-2 ADAMANTANYL-2-PHENOXY-ACETAMIDE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2007-06-20 | — | — | EP | disclosed |
| WO-2006024627-A2 | N-2 ADAMANTANYL-2-PHENOXY-ACETAMIDE DERIVATIVES AS 11-BETA HYDROXYSTEROID DEHYDROGENASE INHIBITORS | JANSSEN PHARMACEUTICA N.V. (BE) | 2006-03-09 | — | — | WO | disclosed |
| CN-1724532-A | Colorant compound | XEROX CORP (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1724597-A | Phase change inks | XEROX CORP (US) | 2006-01-25 | — | — | CN | disclosed |
| CN-1046524-C | Cephalosporin derivatives | HOFFMANN LA ROCHE (CH) | 1999-11-17 | — | — | CN | disclosed |
| CN-1171400-A | Xantone compounds, their production and use | TAKEDA CHEMICAL INDUSTRIES LTD (JP) | 1998-01-28 | — | — | CN | disclosed |
| CN-1105365-A | Cephalosporin derivatives | HOFFMANN LA ROCHE (CH) | 1995-07-19 | — | — | CN | disclosed |
| CN-1019387-B | PROCESS FOR PREPN. OF PROPANOL DERIVATIVES | SYN TEK AB (SE) | 1992-12-09 | — | — | CN | disclosed |
| CN-86100170-A | The preparation method of propanol derivative | — | 1986-12-17 | — | — | CN | disclosed |